Showing results (111-120 of 169) with videos related to
Sort By:
Pageof 17
European Journal of Pharmacology|October 1, 1992
Lack of intrinsic activity and significant subtype selectivity of SR 95639A at muscarinic receptorsA S Mohamed, C Forray, M H Aly, et al.Plos One|November 24, 2011
Subtype differences in pre-coupling of muscarinic acetylcholine receptorsJan Jakubík, Helena Janíčková, Alena Randáková, et al.Neurochemical Research|April 1, 1994
Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl esterC Iadecola, X Xu, F Zhang, et al.Biochemical and Biophysical Research Communications|August 16, 1990
Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniquesC M Arroyo, C Forray, E E el-Fakahany, et al.Scientific Reports|January 17, 2017
Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptorsJan Jakubík, Alena Randáková, Pavel Zimčík, et al.European Journal of Pharmacology|November 11, 1999
The assessment of antagonist potency under conditions of transient response kineticsA Christopoulos, A M Parsons, M J Lew, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Activation of muscarinic acetylcholine receptors via their allosteric binding sitesJ Jakubík, L Bacáková, V Lisá, et al.European Journal of Pharmacology|January 18, 1996
Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncouplingS Z Wang, R Edmundson, S Z Zhu, et al.The Biochemical Journal|February 1, 1991
N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cellsS Pou, W S Pou, G M Rosen, et al.Scientific Reports|September 4, 2020
The operational model of allosteric modulation of pharmacological agonismJan Jakubík, Alena Randáková, Nikolai Chetverikov, et al.Pageof 17